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RESEARCH
Chronic cigarette smoking is linked 
with structural alterations in brain regions 
showing acute nicotinic drug-induced 
functional modulations
Matthew T. Sutherland1* , Michael C. Riedel1,2, Jessica S. Flannery1, Julio A. Yanes3, Peter T. Fox4,5,6, 
Elliot A. Stein7 and Angela R. Laird2
Abstract 
Background: Whereas acute nicotine administration alters brain function which may, in turn, contribute to 
enhanced attention and performance, chronic cigarette smoking is linked with regional brain atrophy and poorer 
cognition. However, results from structural magnetic resonance imaging (MRI) studies comparing smokers versus 
nonsmokers have been inconsistent and measures of gray matter possess limited ability to inform functional relations 
or behavioral implications. The purpose of this study was to address these interpretational challenges through meta-
analytic techniques in the service of clarifying the impact of chronic smoking on gray matter integrity and more fully 
contextualizing such structural alterations.
Methods: We first conducted a coordinate-based meta-analysis of structural MRI studies to identify consistent struc-
tural alterations associated with chronic smoking. Subsequently, we conducted two additional meta-analytic assess-
ments to enhance insight into potential functional and behavioral relations. Specifically, we performed a multimodal 
meta-analytic assessment to test the structural–functional hypothesis that smoking-related structural alterations 
overlapped those same regions showing acute nicotinic drug-induced functional modulations. Finally, we employed 
database driven tools to identify pairs of structurally impacted regions that were also functionally related via meta-
analytic connectivity modeling, and then delineated behavioral phenomena associated with such functional interac-
tions via behavioral decoding.
Results: Across studies, smoking was associated with convergent structural decreases in the left insula, right cerebel-
lum, parahippocampus, multiple prefrontal cortex (PFC) regions, and the thalamus. Indicating a structural–functional 
relation, we observed that smoking-related gray matter decreases overlapped with the acute functional effects of 
nicotinic agonist administration in the left insula, ventromedial PFC, and mediodorsal thalamus. Suggesting structural-
behavioral implications, we observed that the left insula’s task-based, functional interactions with multiple other 
structurally impacted regions were linked with pain perception, the right cerebellum’s interactions with other regions 
were associated with overt body movements, interactions between the parahippocampus and thalamus were linked 
with memory processes, and interactions between medial PFC regions were associated with face processing.
Conclusions: Collectively, these findings emphasize brain regions (e.g., ventromedial PFC, insula, thalamus) critically 
linked with cigarette smoking, suggest neuroimaging paradigms warranting additional consideration among smokers 
(e.g., pain processing), and highlight regions in need of further elucidation in addiction (e.g., cerebellum).
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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Background
Over the past two decades, neuroimaging has contributed 
important insight into the structural and functional brain 
alterations linked with drug abuse in general [1–3] and 
nicotine addiction in particular [4–6]. For example, such 
studies have revealed that nicotine administration alters 
functional brain activity, inducing enhanced activity in 
some regions involved with attention and cognition (e.g., 
thalamus, lateral frontoparietal cortices, anterior cingu-
late cortex [ACC]) yet reducing activity in other regions 
involved with task-irrelevant mental operations (e.g., 
mind wandering; ventromedial prefrontal  cortex, pos-
terior cingulate  cortex, parahippocampus) [6–8]. These 
functional brain alterations may, in part, provide a neu-
robiological account of the well-documented cognitive 
enhancing properties of acute nicotine administration [9, 
10]. On the other hand, chronic cigarette smokers, com-
pared with nonsmokers, exhibit poorer global cognition 
and impaired performance on specific measures of work-
ing memory, cognitive flexibility, visuospatial learning and 
memory, and processing speed [11–13]. Aligning with 
such neurocognitive observations, structural magnetic 
resonance imaging (MRI) studies have detected reduced 
gray matter integrity among smokers in multiple dis-
crete brain regions including the prefrontal cortex (PFC), 
ACC, insula, thalamus, and cerebellum [e.g., 14–17]. Such 
regional atrophy may result from the deleterious impact 
of cigarette smoking and/or reflect predisposing neuro-
biological, neurocognitive, or personality factors.
However, structural MRI results among chronic smok-
ers, to some degree, have been inconsistent. For example, 
gray matter in the insula of smokers has been reported to 
be decreased [15, 18, 19], increased [20], or comparable 
to that among nonsmokers [17, 21]. Similarly, whereas 
some studies have detected smoking-related structural 
decreases in the ventromedial PFC [17, 19, 22] or thal-
amus [17, 21, 23], others have not [14, 21, 24]. Hetero-
geneous findings may be the product of cross-sectional 
designs with modest-to-moderate sample sizes, between-
study variability in participant attributes (e.g., varying age 
ranges, smoking histories, sex ratios, or other sociode-
mographic characteristics), and/or methodological dif-
ferences in MRI acquisition or data analysis parameters 
(e.g., smoothing, registration techniques, or normaliza-
tion templates). Such issues constrain interpretations 
from single studies and necessitate the post hoc integra-
tion of results from multiple independently conducted 
studies to better estimate parameters of interest [25]. 
Accordingly, neuroimaging meta-analytic techniques 
have been increasingly adopted to delineate spatially con-
vergent results across studies, including identification of 
consistently observed gray matter alterations among spe-
cific phenotypes [26–28].
Although useful for elucidating potential structural 
alterations among smokers, measures of gray matter are 
limited in their ability to inform interpretation of func-
tional relations or behavioral implications. Regarding 
structural–functional relations, a plausible hypothesis 
is that brain regions showing chronic smoking-related 
structural alterations overlap those same regions show-
ing acute nicotinic drug-induced functional modulations. 
One perspective is that the repeated impact of nicotine 
exposure within discrete brain regions over an individu-
al’s extended smoking history culminates in neuroadap-
tations that may manifest as gray matter perturbations 
in those same regions. An alternative perspective is that 
pre-existing structural alterations may render some indi-
viduals more susceptible to acute pharmacologic effects 
and, in turn, to addiction. Regardless of the causative 
pathway (or combination thereof ), integrating struc-
tural and functional neuroimaging results may provide 
insight into the neurobiological processes potentially 
contributing to the initiation, escalation, and/or main-
tenance of cigarette smoking. In other words, a multi-
modal perspective may allow for enhanced interpretation 
of structural alterations [29, 30]. Regarding structural-
behavioral implications, a frequently posed question not 
easily answered by considering morphometric outcomes 
is: what are the behavioral consequences of structural 
alterations in a particular brain region (or set of regions). 
As opposed to conjectural discussion of behavioral rel-
evance, empirical approaches to more fully contextual-
ize gray matter alterations are of growing interest [e.g., 
31–33]. Such approaches provide an objective means to 
support behavioral interpretations and/or suggest neuro-
imaging paradigms warranting additional consideration 
among a particular phenotype.
In the current study, we aimed to address these inter-
pretational challenges by employing established and 
emergent meta-analytic techniques to clarify the impact 
of cigarette smoking on gray matter integrity and to 
more fully contextualize such morphometic alterations. 
The specific goals of our study were threefold. First, 
we sought to identify convergent structural alterations 
across studies associated with chronic smoking via the 
well-established, coordinate-based activation likelihood 
Keywords: Cigarettes, Nicotine, Addiction, Gray matter, Morphometry, Insula, Mediodorsal thalamus, Ventromedial 
prefrontal cortex, Cerebellum
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estimation (ALE) meta-analytic framework. We opera-
tionalized the effects of chronic smoking as gray mat-
ter alterations identified in studies utilizing smoker 
versus nonsmoker comparisons. Second, we tested the 
structural–functional hypothesis that chronic smok-
ing-related gray matter alterations overlap those same 
regions showing acute nicotinic drug-induced func-
tional effects via a multimodal meta-analytic assessment. 
Whereas we operationalized chronic effects as structural 
alterations identified in smoker versus nonsmoker (i.e., 
between-subjects) comparisons, we operationalized the 
acute effects of nicotinic acetylcholine receptor (nAChR) 
agonist administration as functional alterations indenti-
fied in pharmacological neuroimaging studies, the vast 
majority of which employed within-subjects (i.e.,  drug 
versus control condition) comparisons. Third, we sought 
to provide enhanced structural-behavioral insight via 
emergent database driven meta-analytic tools, which 
allow for the characterization of typical patterns of 
task-based co-activation and associated behavioral phe-
nomenon for user-specified seed regions of interest. 
Specifically, using smoking-related gray matter altera-
tions to define seed regions, we performed meta-analytic 
connectivity modeling [33] and behavioral decoding 
assessments [34, 35] on data archived in an extensive 
neuroimaging repository (http://www.brainmap.org/) to 
objectively support behavioral interpretations of struc-
tural alterations.
Methods
Structural MRI study search and selection
We performed an iterative literature search to com-
pile structural neuroimaging studies interrogating gray 
matter alterations among chronic cigarette smokers 
compared with nonsmokers. In the first iteration, we 
searched the Web of Science (http://www.webofknowl-
edge.com) and PubMed (http://www.pubmed.gov) data-
bases for peer-reviewed articles with the following logical 
conjunction of terms: (“voxel-based morphometry” OR 
“morphometry” OR “gray matter density” OR “gray mat-
ter volume”) AND (“nicotine” OR “tobacco” OR “ciga-
rette” OR “smok*”). In a second iteration, we consulted 
the bibliographies of recent review articles [5, 36] and 
one existing meta-analysis [37] for studies potentially 
not identified by the database queries. Although a previ-
ous meta-analysis has considered the structural impact 
of chronic smoking, we note that several additional stud-
ies have emerged subsequent to that report and highlight 
our emphasis on structural–functional and structural-
behavioral relations as a further distinguishing character-
istic. In a final iteration, we tracked the references of and 
citations to relevant papers, thereby compiling additional 
studies.
We included studies in this meta-analysis that: (1) 
assessed gray matter using structural MRI, (2) reported 
a set of coordinates (i.e., foci) from a between-subjects 
contrast comparing smokers to matched nonsmoking 
participants, (3) reported coordinates in a defined stere-
otaxic space (i.e., Talairach or Montreal Neurological 
Institute [MNI]), (4) performed a whole-brain analysis, 
and (5) provided sufficient information regarding charac-
terization of smoking behaviors (e.g., pack-years, Fager-
ström Test of Nicotine Dependence [FTND] scores, years 
smoking, number of cigarettes smoked per day), basic 
demographics of the study samples (e.g., age, sex, N), and 
data analysis strategies (e.g., smoothing parameters, sta-
tistical thresholds).
Accordingly, we identified 15 peer-reviewed articles 
involving 761 cigarette smokers and 1182 nonsmokers 
(Additional file  1: Figure S1; Table S1) [14, 15, 17–24, 
38–42]. Across these 15 identified studies, the smoker 
samples were on average 41.8 ± 16.2 (mean ± SD) years 
of age and were composed of 40.9 ± 25.6 % females. At 
the time of scanning, smokers reported cigarette use for 
22.9 ±  17.0 years, smoked 17 ±  4.0 cigarettes per day, 
and were moderately nicotine dependent as indicated 
by FTND scores (4.5 ± 1.3 out of 10). These characteris-
tics were rather consistent across studies and are gener-
ally representative of community-based samples of 
smokers. The nonsmoker samples did not differ from 
smokers in terms of age (41.1 ± 17.5 years; t[14] = −0.9, 
p  =  0.4) or sex (41.6  ±  25.0  % female: t[13]1  =  0.5, 
p = 0.6). Most studies mitigated the influence of other 
drug use by screening via interview and/or urine toxi-
cology on scan days (11 of 15 studies; Additional file 1: 
Table S2). For each study, we also tabulated information 
on the type of MRI scanner used and data collection/
analysis parameters (Additional file  1: Table S2). All 
included studies utilized significance thresholds cor-
rected for multiple comparisons or uncorrected thresh-
olds combined with a spatial extent criterion. These 
studies distinguished gray matter alterations by the 
nonsmoker  >  smoker (i.e., smoking-related decreases) 
and smoker  >  nonsmoker directions (i.e., smoking-
related increases). Of those included, 14 studies (78 
foci) reported gray matter decreases among smokers 
and 5 studies (10 foci) reported increases. Given the 
limited number of studies and recent arguments that 
ALE meta-analyses based on less than 10 experiments/
studies run the risk of obtaining results driven by a sin-
gle experiment as opposed to identifying convergence 
across experiments [43], gray matter increases were not 
considered further.
1 Paired sample t test. One study did not report the number of females/
males.
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Structural impact of chronic cigarette smoking: 
meta‑analytic procedures
To identify areas of convergent gray matter decreases 
across studies, we performed a coordinate-based meta-
analysis using the revised version [44, 45] of the activa-
tion (in this application, Anatomic) likelihood estimation 
(ALE) algorithm [26, 46] as implemented in GingerALE 
v2.3.4 (http://www.brainmap.org/ale/). ALE is a voxel-
wise approach for combining neuroimaging results 
across a collection of experiments/contrasts and thereby 
identifying locations of statistically significant spatial 
convergence. The ALE framework models foci as centers 
of three-dimensional Gaussian probability distributions, 
thus accounting for spatial uncertainty due to within- 
and between-study variability. Foci are weighted by study 
sample size, where larger samples are associated with nar-
rower distributions and smaller samples with wider dis-
tributions. We first linearly transformed foci reported in 
MNI to Talairach space [47] and then generated modeled 
maps of each individual contrast using their respective 
foci (paralleling the modeled activation maps of func-
tional MRI [fMRI] meta-analyses). Next, we calculated 
a voxel-wise ALE score (i.e., the union of all contrasts’ 
modeled maps) quantifying the spatial convergence of 
structural alterations across the brain. To identify clus-
ters of statistically significant convergence, we compared 
these obtained ALE scores with those from an empirical 
null-distribution derived from a permutation procedure 
[27]. This comparison resulted in nonparametric p value 
maps, which we then thresholded at a cluster-corrected 
level (pcorrected < 0.05; voxel-level: p < 0.005, cluster extent: 
344  mm3) and exported to MANGO (http://www.ric.
uthscsa.edu/mango/) for visualization on an anatomical 
(Talairach) template.
Conjoint chronic smoking‑related structural effects 
and acute drug‑induced functional effects: multimodal 
meta‑analytic procedures
We leveraged previous meta-analytic outcomes regard-
ing the impact of acute nAChR agonist exposure on brain 
function to enhance interpretation of structural altera-
tions observed among chronic cigarette smokers. Spe-
cifically, in a previous meta-analysis [6] we identified 38 
pharmacological fMRI studies that assessed the acute 
functional effects of nAChR agonist administration (i.e. 
pharmacologic administration or cigarette smoking) rela-
tive to a baseline condition (i.e., placebo administration 
or smoking abstinence condition) across various cogni-
tive and affective neuroimaging paradigms. The studies 
meeting selection criteria in that functional meta-analy-
sis involved 796 participants, reported 364 foci from 77 
contrasts, and distinguished functional activity modula-
tions by the baseline  >  drug (i.e., activity decrease) and 
drug  >  baseline (i.e., activity increase) directions. We 
characterized the impact of nAChR agonists on brain 
function using the ALE framework (paralleling that 
described above) and separately identified brain regions 
showing either convergent activity increases or decreases 
using a cluster-level corrected threshold (pcorrected < 0.05).
To test the hypothesis that smoking-related gray mat-
ter decreases overlap those same regions showing acute 
drug-induced effects, we conducted a multimodal meta-
analytic assessment. Specifically, we performed a con-
junction analysis to identify those brain regions, if any, 
showing statistically significant convergence when con-
sidering both: (1) chronic smoking-related structural 
effects (smokers versus nonsmokers), and (2) acute 
drug-induced functional effects (nAChR agonist manipu-
lation versus control condition). Employing a conserva-
tive minimum statistic conjunction [48], we identified 
brain regions showing conjoint structural and functional 
effects by computing the intersection of the two thresh-
olded meta-analytic maps combined with an additional 
overlap-cluster extent criterion (100 mm3).
Behavioral relevance of structurally impacted regions: 
meta‑analytic connectivity modeling and behavioral 
decoding
As gray matter assessments possess limited ability to 
inform functional or behavioral interpretations, we 
subsequently employed emergent meta-analytic tools 
to more fully contextualize the brain circuit-level and 
behavioral consequences of structural alterations iden-
tified among smokers [28, 49, 50]. Specifically, to deter-
mine whether structurally impacted brain regions reflect 
disruption of functionally interrelated neurocircuits, we 
utilized meta-analytic connectivity modeling (MACM), 
a validated database driven approach for delineating 
brain areas that co-activate with a seed region of interest 
(ROI) across many neuroimaging tasks [33, 51, 52]. This 
assessment was conducted using the BrainMap database 
(http://www.brainmap.org/) which is an online reposi-
tory of over 13,500 neuroimaging contrasts from ~2800 
journal articles (as of January, 2016) archived as three-
dimensional coordinate-based results (x, y, z) as well as 
relevant metadata describing the associated experimen-
tal design [53–55]. Whereas we utilized the database’s 
archived activation coordinates to characterize the co-
activation/connectional profile of structurally-identified 
ROIs, we utilized the metadata to facilitate behavioral 
interpretation of smoking-related structural alterations 
via meta-analytic behavioral decoding. Although the 
data utilized in these assessments were from healthy par-
ticipants, they nonetheless offer a useful path to enhance 
interpretation of observed structural alterations among 
smokers. These analyses attempt to identify within a 
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typical range of function whether pairs of regions inter-
act and, if so, under what behavioral context. If two brain 
regions are structurally impacted by a certain neuropsy-
chiatric condition and those same regions also appear 
to interact among healthy participants under a specific 
behavioral context, one plausible inductive conclusion 
is that the psychological processes associated with that 
behavioral context may be disrupted in the neuropsychi-
atric condition.
Moving beyond isolated regions, we conducted a 
MACM assessment to characterize the typical pattern 
of task-based, whole-brain co-activation for each of the 
structurally-identified ROIs. A MACM assessment aims 
to identify, across a domain-arching pool of studies inter-
rogating various mental operations and task paradigms, 
brain areas that simultaneously co-activate with a user-
specified seed region. In other words, a MACM assess-
ment identifies brain areas most likely to be activated 
across all tasks, given activation within a seed. Similar to 
seed-based resting-state functional connectivity assess-
ments of fMRI data, a MACM identifies those regions 
that are significantly related to, and presumably inter-
act with the seed. First, we identified experiments in the 
database that reported one or more activation coordi-
nates within a seed ROI using the Sleuth software appli-
cation (http://www.brainmap.org/sleuth/). The seeds 
were 8  mm radius spheres centered on the voxels with 
maximum ALE values within each of the smoking-related 
gray matter loss regions identified above. We conducted 
separate searches and computed separate MACMs for 
each of these ROIs. As practiced in previous MACM 
assessments to achieve sufficient power [e.g., 56], only 
those ROIs associated with 30 or more experiments in 
the database were considered for further analyses. We 
employed 8 mm radial spheres to equate each ROIs vol-
ume and to seek a balance between returning a sufficient 
number of experiments from the database and minimiz-
ing overlap between ROIs that were in close proxim-
ity. Next, we extracted the whole-brain coordinates of 
all foci that co-activated with the seed, constraining this 
extraction to only activation foci (i.e., no deactivations) 
reported in studies examining healthy participants (i.e., 
no intervention or group comparisons). After converting 
foci reported in MNI to Talairach space [47], we supplied 
these foci as input to the ALE methodology described 
above thereby delineating regions of convergent co-acti-
vation with the seed when employing a cluster-corrected 
threshold of pcorrected < 0.05 (voxel-level: p < 0.001). These 
thresholded MACM maps for each ROI represent the 
above-chance probability that identified voxels co-acti-
vated with the respective seed across many neuroimag-
ing tasks. To determine whether smoking-related gray 
matter loss regions reflected disruption of functionally 
interrelated neurocircuits, we quantified the degree to 
which one ROI’s MACM map intersected with any of the 
other structurally impacted ROIs. If one ROI’s MACM 
map overlapped at least 50 voxels of any other ROI, those 
two regions were considered to constitute a circuit-level 
functional interaction.
In addition to the co-activation coordinates, we also 
extracted the corresponding BrainMap metadata allow-
ing for the generation of behavioral profiles for each pair 
of co-activating, and presumably functionally-related, 
ROIs. The metadata in the database are coded according 
to a well-defined taxonomy (http://www.brainmap.org/
taxonomy/) cataloguing each contributing study’s experi-
mental design, stimulus type, behavioral domain (and 
subcategory), and paradigm class [57, 58]. Under this 
taxonomy, behavioral domains (BD) represent the men-
tal processes interrogated by the primary study’s statisti-
cal contrasts and comprise the main categories of action, 
cognition, emotion, interoception, and perception as well 
as BD subcategories (BD-S; e.g., perception: somesthesis-
pain). Paradigm classes (PC) further categorize the spe-
cific task employed (e.g., pain monitoring/discrimination, 
Go/No-Go). We used these metadata terms to delineate 
behavioral phenomena linked with the concurrent activa-
tion of those pairs of structurally-identified ROIs consid-
ered to constitute circuit-level functional interactions in 
the above MACM assessments.
Specifically, we created behavioral profiles for circuits of 
interest by performing forward and reverse inference 
analyses [34, 35] on the associated distribution of meta-
data terms [59, 60]. In the forward inference approach, we 
tested whether the conditional probability of brain activa-
tion given a particular behavioral phenomenon (i.e., BD, 
BD-S, or PC), p(Activation|Phenomenon), was higher 
than the baseline probability of brain activation, 
p(Activation). Baseline activation was defined as the prob-
ability of finding a random activation from the database in 
the region(s) of interest. Significance was established with 
a binomial test (pFDR-corrected < 0.05). In the reverse infer-
ence approach, we identified the most likely behavioral 
phenomenon (i.e., BD, BD-S, or PC) given activation in a 
region. This likelihood, p(Phenomenon|Activation), was 
derived from p(Activation|Phenomenon) as well as 
p(Phenomenon) and p(Activation) using Bayes’ Rule. Sig-
nificance was established with a Chi-squared test 
(pFDR-corrected  <  0.05). Only BD, BD-S, and PC terms that 
were significant in both the forward and reverse inference 
approaches are reported.2
2 We note that these analyses represent an attempt to relate behavioral 
phenomena with identified ROIs as opposed to claiming “a unique role” of 
those ROIs with respect to behavior [34]. In other words, an association of 
“behavioral phenomenon x to brain region y” obtained from these analyses 
does not necessarily imply that activity in “region y is limited to behavioral 
phenomenon x”.
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Results
Structural impact of chronic cigarette smoking
To elucidate structural alterations associated with an 
extended smoking history, we conducted a meta-anal-
ysis identifying consistent gray matter decreases among 
smokers. This meta-analysis included 78 distinct foci 
from 14 peer-reviewed studies involving a total of 750 
smokers and 1073 nonsmokers (Additional file  1: Table 
S1). Across these studies, ALE revealed convergent gray 
matter decreases in 12 distinct clusters, notably in the 
ventromedial PFC (vmPFC), left insula, and mediodor-
sal (MD) thalamus, as well as in the medial orbitofrontal 
cortex (mOFC), ventrolateral PFC (vlPFC), dorsomedial 
PFC (dmPFC), medial PFC (mPFC), left parahippocam-
pal gyrus, and right cerebellum (Fig. 1; Table 1). 
Conjoint chronic smoking‑related structural effects 
and acute drug‑induced functional effects
To delineate regions displaying both structural alterations 
linked with chronic smoking and functional modulations 
linked with acute nicotinic agonist administration, we 
performed a multimodal assessment. Specifically, we con-
ducted a conjunction analysis identifying regions showing 
both convergent: (1) smoking-related structural decreases 
(Fig.  1), and (2) nAChR agonist-induced functional 
decreases or increases [6]. This multimodal assessment 
identified overlapping structural and functional effects 
within the vmPFC, left insula, and MD thalamus (Fig. 2; 
Table  2). Specifically, whereas gray matter decreases in 
the vmPFC and insula overlapped with clusters of acute 
drug-induced functional activity decreases (Fig. 2, green; 
Additional file 1: Figure S2), gray matter decreases in MD 
thalamus overlapped with drug-induced activity increases 
(Fig.  2, orange; Additional file  1: Figure S3). We arrived 
at similar outcomes and the same conclusions when per-
forming this multimodal assessment when considering 
only functional studies involving nicotine administration 
(i.e., excluding other nAChR agonists; Additional file  1: 
Figure S4) and when considering only functional results 
involving cigarette smokers (Additional file 1: Figure S5). 
Behavioral relevance of structurally impacted regions: 
MACM and behavioral decoding
To enhance insight into the circuit-level consequences 
of smoking-related structural alterations, we first per-
formed a MACM assessment thereby identifying clusters 
Fig. 1 Structural impact of chronic cigarette smoking. Convergent gray matter decreases among smokers (nonsmokers > smokers) were observed 
notably in multiple PFC regions, the left insula, thalamus, and cerebellum. Numbering corresponds to coordinates listed in Table 1
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Table 1 Convergent gray matter decreases associated with chronic smoking: cluster coordinates
Numbering corresponds to brain regions shown in Fig. 1. Coordinates (X, Y, Z) of the clusters’ peak voxels are reported in Talairach space. Volume is mm3
B bilateral, R right, L left, BA Brodmann area, OFC orbitofrontal cortex, vmPFC ventromedial prefrontal cortex, vlPFC ventrolateral prefrontal cortex, dmPFC dorsomedial 
prefrontal cortex, mPFC medial prefrontal cortex
Cluster Region Volume X Y Z
Nonsmokers > smokers
 1 Thalamus (lateral posterior nucleus) R 592 16 −22 14
 2 dmPFC (BA 6) (superior frontal gyrus) R 576 16 24 52
 3 vmPFC (BA10) (superior frontal gyrus) L 568 −8 56 −4
 4 vlPFC (BA 10) (middle frontal gyrus) R 480 32 46 4
 5 dmPFC (BA 8) (medial frontal gyrus) R 480 10 40 36
 6 Parahippocampal gyrus L 432 −20 −34 0
 7 mPFC (BA10) (medial frontal gyrus) R 416 12 58 8
 8 Medial OFC (BA 11) B 384 2 34 −20
 9 mPFC (BA10) (medial frontal gyrus) L 376 −14 58 8
 10 Cerebellum (dentate) R 368 14 −58 −20
 11 Insula (BA 13) L 368 −40 8 10
 12 Thalamus (medial dorsal nucleus) B 360 2 −18 4
Fig. 2 Conjoint structural and functional effects. Structural alterations (nonsmokers > smokers) overlapped with acute drug-induced activity 
decreases (baseline > drug) in the insula and ventromedial PFC (green a, b). Structural alterations (nonsmokers > smokers) overlapped with acute 
drug-induced activity increases (drug > baseline) in the mediodorsal thalamus (orange c). Lettering corresponds to coordinates listed in Table 2. See 
Additional file 1: Figures S2 and S3 for visualization of overlapping and non-overlapping regions from the structural and functional meta-analyses
Table 2 Conjoint chronic smoking-related structural alterations and  acute drug-induced functional activity changes: 
cluster coordinates
Lettering corresponds to brain regions shown in Fig. 2. Coordinates (X, Y, Z) of the clusters’ peak voxels are reported in Talairach space. Volume is mm3
B bilateral, R right, L left, BA Brodmann area, vmPFC ventromedial prefrontal cortex
Cluster Region Volume X Y Z
Gray matter decreases ∩ functional decreases
a Insula (BA 13) L 185 −39 7 9
b vmPFC (BA10) (superior frontal gyrus) L 103 −9 50 −3
Gray matter decreases ∩ functional increases
c Thalamus (medial dorsal nucleus) B 142 2 −14 11
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of convergent co-activation for each of the structurally 
impacted ROIs. One region (mOFC) failed to return a 
sufficient number of experiments from the BrainMap 
database and was not considered further (Additional 
file  1: Table S3). The remaining 11 whole-brain MACM 
maps represent voxels with an above-chance probability 
of co-activating with the seed when considering vari-
ous neuroimaging tasks (Fig.  3; Additional file  1: Table 
S4). For example, the MACM map for: (1) the vmPFC 
seed (Fig. 3, ROI 3) indentified convergent co-activation 
within the posterior cingulate cortex, dmPFC, parahip-
pocampus, and inferior frontal gyrus, (2) the left insula 
seed (Fig.  3, ROI 11) displayed notable co-activation 
with the right insula, posterior medial prefrontal cortex 
(encompassing the ACC and supplemental motor area), 
the thalamus, parietal cortex, and cerebellum, and (3) the 
MD thalamus seed (Fig. 3, ROI 12) encompassed the pos-
terior medial PFC, bilateral insula, parietal cortex, and 
cerebellar regions. These and similarly-derived MACM 
maps delineating networks of task-based co-activation 
resemble networks identified when considering task-
independent resting-state fMRI data [28, 61–64].
We then further assessed these co-activation maps 
to determine whether structurally impacted regions 
reflected functionally interrelated neurocircuits. Those 
structurally impacted ROIs that also appeared to be 
functionally related are summarized in Fig.  4a. In this 
representation, the paths between regions indicate the 
observation of one ROI intersecting with another ROI’s 
MACM map. For example, the left insula’s MACM map 
(Fig.  4a, ROI 11) overlapped the lateral posterior thala-
mus (ROI 1), cerebellum (ROI 10), and the MD thalamus 
(ROI 12) and vice versa (represented by double-headed 
arrows), whereas the left insula ROI was overlapped 
by the MACM map derived for the vlPFC seed (ROI 4, 
single-headed arrow). For the 11 ROIs, 12 unique paths 
were identified (out of 55; Additional file  1: Figure S6) 
representing pairs of regions with an above-chance prob-
ability of co-activation.
To characterize behavioral phenomena linked with 
these pairs of functionally-related ROIs, we performed 
behavioral decoding via forward and reverse inference 
techniques on the associated BrainMap metadata terms 
(BD, BD-S, and PC). Those behavioral phenomena sig-
nificantly associated with co-activation of ROI pairs are 
represented in Fig.  4b. We highlight four observations 
from this assessment. First, the left insula’s co-activation 
with multiple other ROIs was linked with aspects of pain 
processing. Specifically, insula and vlPFC co-activation 
(Fig. 4b, path: ROI 4–11) was significantly associated with 
the BD perception (purple), the BD-S somesthesis-pain, 
and the PC pain monitoring/discrimination. Similarly, 
concurrent activation of the insula and MD thalamus 
(Fig.  4b, path: ROI 11–12) was linked with perception, 
somesthesis-pain, and pain monitoring/discrimination 
in addition to the PC recitation/repetition (overt). Insula 
and lateral posterior thalamus co-activation (Fig.  4b, 
path: ROI 11–1) was associated with perception and som-
esthesis-pain. Second, the right cerebellum’s co-activation 
with multiple other ROIs was related to aspects of overt 
body movements. Specifically, cerebellum and insula co-
activation (Fig. 4b, path: ROI 10–11) was associated with 
the BD action (red), the BD-S execution-speech, and the 
PC recitation/repetition. Similarly, concurrent activation 
of the cerebellum and MD thalamus (Fig. 4b, path: ROI 
10–12) was related to action, execution (non-speech), 
execution-speech, and recitation/repetition in addition to 
the PCs of flexion/extension and Go/No-Go (i.e., inhibit-
ing an overt body movement). Co-activation of the cer-
ebellum and lateral posterior thalamus (Fig.  4b, path: 
ROI 10–1) was linked with the BD action, BD-S execu-
tion (non-speech), and PC finger tapping/button press. 
Third, co-activation of the parahippocampus and MD 
thalamus (Fig.  4b, path: ROI 6–11) was related to the 
BD cognition (green), the BD-S memory-explicit, and the 
PCs cued-explicit and recognition/recall. Lastly, concur-
rent activation of the vmPFC and mPFC (Fig.  4b, path: 
ROI 3–9) was associated with the PC face monitoring/
discrimination.
Discussion
We compiled structural MRI results to clarify the impact 
of cigarette smoking on gray matter integrity. Our 
meta-analytic results revealed convergent gray matter 
decreases among smokers in multiple regions includ-
ing the prefrontal cortex, insula, thalamus, and cerebel-
lum. Given that such structural measures provide limited 
insight into functional or behavioral implications, we 
subsequently performed two additional meta-analytic 
assessments to more fully contextualize these gray matter 
decreases. Indicative of a structural–functional relation, 
we observed via a multimodal assessment that chronic 
smoking-related structural effects overlapped with the 
acute functional effects of nAChR agonist administration 
in the vmPFC, left insula, and MD thalamus. Suggestive 
of structural-behavioral implications, we then identified 
pairs of structurally impacted regions that tended to co-
activate across various tasks and delineated behavioral 
phenomena linked with such co-activation via MACM 
and behavioral decoding, respectively. These assessments 
linked the left insula’s co-activation with multiple other 
brain regions to pain perception, the right cerebellum’s 
co-activation with other regions to overt body move-
ment, co-activation of the parahippocampus and MD 
thalamus with memory processes, and co-activation of 
medial PFC regions with face processing.
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Across studies, we observed convergent smoking-
related structural decreases in discrete brain regions 
notably in the PFC (i.e., ventromedial, ventrolateral, 
dorsomedial, orbitofrontal), insula, thalamus, and cer-
ebellum. Although we can only speculate on the patho-
genesis of such decreases, structural differences between 
Fig. 3 Meta-analytic connectivity modeling (MACM) maps of task-related co-activation for each structurally impacted ROI. These thresholded 
MACM maps (pcorrected < 0.05) represent voxels with an above-chance probability of co-activating with the respective seed regions (8 mm radius 
spheres centered on the voxels with maximum ALE values within each smoking-related gray matter loss region). One region (ROI 8; mOFC) failed 
to return a sufficient number of contrasts from the database and was omitted from further analyses. Numbering corresponds to that in Table 1. The 
seed ROI of each MACM map is outlined in red. MACM maps for ROIs boxed in red are discussed in the main text. See Additional file 1: Table S4 for 
each seed ROI’s co-activation coordinates
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smokers and nonsmokers could be products of predis-
posing neurobiological risk factors [65], the deleterious 
impact of cigarette smoking on microvascular function-
ing [66], neurotoxic events (e.g., oxidative stress, inflam-
mation) associated with many of the  >4000 compounds 
present in tobacco smoke [67], and/or be mediated 
directly or indirectly by nicotine itself. Focusing on the 
last possibility, nAChRs are ubiquitous throughout the 
human brain with particularly high densities in the thala-
mus, insula, and vmPFC [68, 69]. Widespread upregula-
tion of nAChRs, likely related to receptor desensitization 
from nicotine exposure, has been observed among smok-
ers [70, 71] and, conversely, smoking cessation associ-
ated with decreases in regional nAChR densities [72]. 
Evidence from preclinical models suggests neurotoxic 
events and protracted consequences on cholinergic 
neurotransmission following nicotine exposure particu-
larly during adolescence [73–75]. As such, one plausible 
mechanistic account is that repeated stimulation of high 
densities of nAChRs by nicotine may contribute to neu-
rotoxicity within discrete regions and/or increase the vul-
nerability of those regions to other volatile compounds 
in tobacco smoke [19] which ultimately manifest as gray 
matter decreases.
Speaking to such an account, we conducted a mul-
timodal meta-analytic assessment to determine if 
smoking-related structural decreases overlapped with 
nicotinic agonist-induced functional modulations and 
observed conjoint effects in the vmPFC, insula, and 
MD thalamus. In addition to possessing relatively high 
nAChR densities, these regions also are critically impli-
cated in addiction-related psychological processes. For 
example, the vmPFC, in concert with other regions such 
as the OFC and striatum, is thought to play a role in rep-
resenting subjective value information, behavioral choice 
selection, and evaluating outcomes and alterative rewards 
[76–78]. The insula, a functionally heterogeneous region, 
is involved with monitoring the physiological state of the 
body, appears causally related to the initiation, mainte-
nance, and adjustment of attentional control, and likely 
plays a role in maladaptive decision-making among drug 
addicts [79–82]. Dysfunction of the MD thalamus, a 
primary node within a thalamic-PFC-basal ganglia net-
work involved in associative learning, is implicated in the 
Fig. 4 Pairs of functionally-related ROIs and associated behavioral phenomena. a Functionally-related ROIs are connected by paths, the direction-
ality of which indicates that a given ROI (ending point, arrow head) intersected another ROIs MACM map (starting point). We note that if one ROI 
overlapped another ROI’s MACM map, it did not necessarily indicate that the latter ROI overlapped with the former’s MACM map. See Additional 
file 1: Figure S6 for an alternative representation. b Behavioral phenomena significantly associated with functionally-related ROIs were identified by 
forward and reverse inference assessments of metadata terms. In this representation, significant behavioral domains (BD) are represented by path 
color (perception [purple], action [red], cognition [green], no significant BD [gray]), significant behavioral domain subcategories (BD-S) are shown 
along the path in bolded text, and significant paradigm classes (PC) are in standard text. Black paths indicate that no significant associations were 
detected with any BD, BD-S, or PC
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transition from goal-directed action (e.g., recreational 
drug use) to habitual forms of responding (e.g., dysregu-
lated drug seeking) [83, 84]. Consistent with the notion 
that structural alterations in these regions are a prod-
uct of prolonged nicotine/tobacco exposure, group dif-
ferences between smokers and nonsmokers within, for 
example, the insula were not detected among an adoles-
cent/young adult participant sample with relatively lower 
exposure levels (0.9  ±  0.7 pack-years on average) [85] 
but were observed among similarly aged individuals with 
relatively higher exposure levels (4.0  ±  1.8 pack-years) 
[86]. Furthermore, multiple studies have provided evi-
dence for dose-dependent exposure effects on gray mat-
ter integrity within the insula [18, 85] and vmPFC [19, 22, 
86] as well as within the lateral PFC [14, 20] and cerebel-
lum [23]. Widespread dose-dependent negative relations 
between pack-years and cortical thickness were recently 
corroborated in a large sample of older adults (N > 500) 
with particularly robust effects in the medial and lateral 
PFC [87]. Interestingly, positive relations between num-
ber of years since last cigarette and cortical thickness, 
suggesting potential recovery with smoking cessation, 
were also detected in medial PFC and posterior insula 
regions, amongst others [87]. Our multimodal meta-
analytic outcomes add to a growing literature implicating 
the vmPFC, insula, and thalamus as contributors to the 
initiation, escalation, maintenance, and/or cessation of 
cigarette smoking.
Representing one objective approach for providing 
insight into the behavioral relevance of convergent gray 
matter decreases among smokers, we utilized emergent 
meta-analytic tools to delineate structurally impacted 
ROIs that tended to co-activate and their associated 
behavioral phenomena. Similar approaches have been 
used to quantitatively aid interpretation of regions iden-
tified via structural assessments or networks commonly 
observed via resting-state fMRI (i.e., assessments inher-
ently lacking direct behavioral insight) [28, 33]. Although 
we adopted a quantitative approach to infer behavioral 
relevance of structural alterations, we note that our inter-
pretations remain largely speculative until experimentally 
verified. We observed that co-activation of the left insula 
with thalamic and lateral PFC regions were generally 
linked with pain perception. Dysregulated pain process-
ing is increasingly recognized as a potential barrier to 
smoking cessation [88, 89] and emerging evidence sug-
gests bidirectional relations between pain and smoking 
behaviors [90, 91]. In laboratory assessments (e.g., cold 
pressor test), minimally-deprived or abstinent smokers, 
compared with nonsmokers, exhibit lower pain tolerance 
and report greater subjective experiences of pain where 
such pain reports positively correlate with nicotine with-
drawal severity [92–94]. As such, nicotine abstinence 
may contribute to enhanced pain sensitivity that could 
maintain cigarette smoking via negative reinforcement 
mechanisms similar to other withdrawal symptoms [95]. 
Although the insula’s role in interoceptive monitoring has 
been well characterized [80] and higher nAChR availabil-
ity in the thalamus, PFC, and cerebellum has been posi-
tively correlated with increased pain sensitivity among 
abstinent smokers [96], relatively little neuroimaging 
work has focused on the neurobiological processes that 
may contribute to smoking- or withdrawal-related pain 
dysregulation. Our meta-analytic outcomes suggest that 
neuroimaging investigations of pain perception among 
smokers, with emphasis on the putative functional inter-
actions between the insula and MD thalamus, may be a 
productive avenue for future research.
We also observed that co-activation of the right cer-
ebellum with insula and thalamic regions were generally 
linked with overt body movements. Acutely adminis-
tered, nicotine augments performance in simple motor 
tasks [9] and increases cerebellar vermis activity during 
externally paced finger tapping [97]. On the other hand, 
chronic cigarette smokers perform worse than nonsmok-
ers on neurocognitive measures of fine motor skills and 
postural stability [11]. Smoking-related decreases in 
right cerebellum gray matter, identified via an ROI-based 
approach [16] (i.e., a study not meeting inclusion crite-
ria for the current meta-analysis), further corroborate 
our observation of convergent decreases in this region. 
Whereas our outcomes are consistent with the cerebel-
lum’s critical role in motor coordination, they also align 
with contemporary views emphasizing the region’s con-
tribution to cognitive processes [98, 99] and relevance 
to drug addiction [100, 101]. For example, we observed 
that co-activation of the cerebellum and MD thalamus 
was significantly associated with Go/No-Go paradigms 
that require inhibitory control. Although current neu-
robiological models of addiction have yet to provide an 
integrative account of this region’s contribution, altered 
cerebellar structure and function appears to be a com-
mon characteristic across drugs of abuse [100]. Our 
meta-analytic outcomes serve to further draw attention 
to the cerebellum in the context of addiction in general 
and cigarette smoking in particular.
Lastly, co-activation of the parahippocampus and MD 
thalamus was linked with memory processes and co-acti-
vation of medial PFC regions linked with face process-
ing. Regarding the former observation, neurocognitive 
assessments have consistently identified visuospatial 
learning and memory deficits among older (>60  years) 
as well as middle-aged smokers (30–60 years) relative to 
nonsmokers [11, 12]. Regarding the latter observation, 
as face processing paradigms often directly or indirectly 
involve affective components, a plausible interpretation 
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is that smoking-related structural effects in medial PFC 
regions may relate to disrupted emotional processing 
and/or regulation [102, 103]. Indeed, smokers tend to 
report elevated negative mood and a reduced ability to 
self-regulate such states when compared with nonsmok-
ers [104, 105].
Our findings should be considered in light of remain-
ing issues. First, the ALE framework is a coordinate-
based meta-analytic approach that does not incorporate 
the size of identified clusters from the primary studies, 
which leads to less precise representations relative to 
image-based approaches [106], which, on the other hand, 
are themselves often less feasible. Second, we only con-
sidered gray matter decreases among smokers owing to a 
small number of reported experiments/foci in the litera-
ture with respect to increases. Nonetheless, neuroimag-
ing studies have documented smoking-related volumetric 
increases in the caudate and putamen [17, 86], positive 
correlations between putamen volume and lifetime nico-
tine/tobacco exposure [107], and positive correlations 
between greater striatal volume and more intense cue-
induced tobacco craving [108]. Third, we followed pre-
vious recommendations that at least 10-15 experiments 
should be included in an ALE meta-analysis and note 
that the meta-analysis identifying gray matter decreases 
among smokers involved 14 studies. Based on recent data 
simulations [43], closer to ~20 experiments has been pre-
scribed to achieve sufficient power to detect moderately 
sized effects. Fourth, meta-analytic results are limited by 
the methodology commonly employed by the included 
studies. With respect to the use of T1-weighted MRIs to 
assess gray matter, we note recent commentaries regard-
ing the potential for drug-induced cerebral blood flow 
alterations to complicate interpretation of structural 
outcomes [109, 110]. Given that many studies included 
in this meta-analysis did not report the time elapsed 
between last cigarette smoked and MRI data collection 
(Additional file  1: Table  S2), this potential confounding 
factor cannot be ruled out. Fifth, our behavioral decod-
ing outcomes are limited by the studies archived in the 
BrainMap database at the time of analysis as well as its 
associated taxonomy. Sixth, although some studies have 
begun to characterize the impact of smoking on gray 
matter in young adult/adolescent smokers [85, 86], the 
concurrent influence of marijuana [111] or alcohol use 
[112], and sex differences among smokers [17], as more 
studies accumulate regarding the influence of these and 
other important factors on gray matter alterations, it 
will become possible to better characterize the specific-
ity of the meta-analytic effects identified herein. Lastly, it 
remains for future work, perhaps through multi-site lon-
gitudinal investigations, to determine whether regional 
structural alterations are a cause or consequence of ciga-
rette smoking (or a combination thereof ) and the extent 
to which such alterations recover following cessation.
In sum, cigarette smoking was associated with con-
vergent structural decreases across studies in the PFC, 
insula, thalamus, and cerebellum. Some of these chronic 
smoking-related structural effects overlapped with 
regions showing acute nicotinic drug-induced functional 
effects. This study highlights the utility of using neuro-
imaging meta-analytic techniques to compile, synthe-
size, and inform neuroimaging investigations aiming to 
elucidate the neurobiological factors underlying the ini-
tiation, escalation, maintenance, and/or cessation of ciga-
rette smoking. Collectively, our findings emphasize brain 
regions (e.g., vmPFC, insula, thalamus) and circuits (e.g., 
insula-thalamus) linked with chronic smoking, suggest 
neuroimaging paradigms warranting additional consider-
ation among smokers (e.g., pain processing), and point to 
regions in need of further elucidation in addiction (e.g., 
cerebellum).
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